| XMRV Update Plus A Possible New Treatment |
|
|
|
Jacob Teitelbaum MD is Medical Director of the Fibromyalgia and Fatigue Centers
(www.fibroandfatigue.com). Senior author of the landmark studies "Effective Treatment of Chronic Fatigue Syndrome and Fibromyalgia -- a Placebo-controlled Study" & Effective Treatment of CFS & Fibromyalgia with D-Ribose. Author of the best-selling book From Fatigued to Fantastic!(3rd ed-Penguin/Avery Oct 4, 2007) , " Three Steps to Happiness! Healing through Joy", and Pain Free 1-2-3- A Proven Program to Get YOU Pain Free! (McGraw Hill, 2006). He does numerous media appearances, including CNN and FOX National News and is a frequent guest on Oprah and Friends with Dr. Oz.. He lives in Kona, Hawaii. Visit his web site at www.Vitality101.com
You can benefit from Dr. Teitelbaum's wisdom and experience by visiting us at The Environmental Illness Resource regularly to read articles from his latest newsletter!
Monday, May 9th, 2011:
So what does this all mean? On one level, likely one of two things: What does it not mean that this study did not find XMRV? It does not say anything about whether CFS & fibromyalgia are real. There are many studies showing numerous infections in CFS/FMS, as is expected in an immune disorder. Treating these infections and the immune dysfunction is an important part of treatment (remember, the "I" in SHINE stands for Infections in the "SHINE Treatment Protocol"). The study also does not change treatment at this time, as we do not recommend the AIDS antivirals that might work against XMRV.
New research opens some exciting and very novel (and low cost) new possibilities for testing and treatment in CFS! As the study authors note, there is "still a wealth of prior data to encourage further research into the involvement of other infectious agents in CFS, and these efforts must continue." More studies are planned to explore the XMRV virus and CFS. At this point though, what is needed to resolve the debate is what we have been recommending for quite a while (see XMRV Controversy Heats Up — Two Important New Studies), and which would simply and clearly answer whether the XMRV found in the WPI testing is real or a contaminant. An independent group (and the ones who did this study would be an excellent choice) should select people to test. Half of the samples sent to the WPI should be from people with clearcut CFS and half from healthy patients, and the samples should be blinded (i.e., not labeled as to whether they are coming from CFS or healthy control patients). If the samples sent to the WPI clearly again come up positive for XMRV in CFS patients and negative for healthy patients, as in the earlier study, it would immediately answer the question of whether XMRV is more common in CFS or whether it was simply lab error. So in real life, there is really a very simple approach that could answer these questions.
Another recent but largely unnoticed study offers: Though the role of XMRV is still a big question mark, this other possibility is very exciting stuff! I am researching the area further and in the process of writing the article, so I hope to have it an upcoming newsletter in the next few weeks. All I can say is it is very fascinating and promising ;-) Stay tuned! Love & blessings, Dr. T
Used with permission from Dr Jacob Teitelbaum's free newsletters-available at www.Vitality101.com
Learn more from Dr. Teitelbaum's books:
Set as favorite
Bookmark
Email this
Hits: 735 Comments (0)
![]() Write comment
|
|||||||||
| Last Updated on Monday, 09 May 2011 12:03 |










